Immune Netw.  2008 Mar;8(1):7-12. 10.4110/in.2008.8.1.7.

Generation and Characterization of Monoclonal Antibodies against Human Interferon-lambda1

Affiliations
  • 1Department of Microbiology and Immunology, Ajou University School of Medicine, Suwon, Korea. sinsun@ajou.ac.kr

Abstract

BACKGROUND
Members belonging to the interferon-lambda (IFN-lambda) family exert protective action against viral infection; however, the mechanisms of their action have remained elusive. To study IFN-lambda biology, such as endocytosis of IFN-lambda, we produced monoclonal antibodies (Abs) against human IFN-lambda and examined their usefulness.
METHODS
We purified recombinant human IFN-lambda1 expressed in Escherichia coli by using affinity columns. Then, we generated hybridoma cells by fusing myeloma cells with splenocytes from IFN-lambda1- immunized mice. For evaluating the neutralizing activity of the monoclonal Abs against IFN-lambda1, we performed RT-PCR for the MxA transcript. In order to study the binding activity of IFN-lambda and the monoclonal Ab complex on HepG2 cells, we labeled the monoclonal Ab with rhodamine and determined the fluorescence intensity.
RESULTS
Four hybridoma clones secreting Abs specific to IFN-lambda1 were generated and designated as HL1, HL2, HL3, and HL4. All the Abs reacted with IFN-lambda1 in the denatured form as well as in the native form. Abs produced by HL1, HL3, and HL4 did not neutralize the induction of the MxA gene by IFN-lambda1. We also demonstrated the binding of the HL1 monoclonal anbitody and IFN-lambda complex on HepG2 cells.
CONCLUSION
Monoclonal Abs against IFN-lambda1 were produced. These Abs can be used to study the cellular binding and internalization of IFN-lambda.

Keyword

Interleukin 29 protein; monoclonal antibody

MeSH Terms

Animals
Antibodies, Monoclonal
Biology
Clone Cells
Endocytosis
Escherichia coli
Fluorescence
Hep G2 Cells
Humans
Hybridomas
Mice
Rhodamines
Antibodies, Monoclonal
Rhodamines
Full Text Links
  • IN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr